Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer C Davies

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Immunology (Orlando, Fla.)|February 5, 2022
Longitudinal analysis of urinary proteins in lupus nephritis - A pilot studyEmil Carlsson, Alexandra Quist, Jennifer C Davies, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 15, 2025
The Use of First-Void Urine to Screen Women Aged 60-79 for HPV in the UK: The Catch-Up Screen StudyChristine Rake, Emma J Davidson, Alex Young, et al.
The Cochrane Database of Systematic Reviews|November 23, 2025
Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysisHanna Bergman, Nicholas Henschke, Ingrid Arevalo-Rodriguez, et al.
The Lancet. Infectious Diseases|September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trialVictoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Lancet (London, England)|December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trialChristopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Immunology (Orlando, Fla.)|February 5, 2022
Longitudinal analysis of urinary proteins in lupus nephritis - A pilot studyEmil Carlsson, Alexandra Quist, Jennifer C Davies, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 15, 2025
The Use of First-Void Urine to Screen Women Aged 60-79 for HPV in the UK: The Catch-Up Screen StudyChristine Rake, Emma J Davidson, Alex Young, et al.
The Cochrane Database of Systematic Reviews|November 23, 2025
Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysisHanna Bergman, Nicholas Henschke, Ingrid Arevalo-Rodriguez, et al.
The Lancet. Infectious Diseases|September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trialVictoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Lancet (London, England)|December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trialChristopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
Pageof 2